2024 HCPCS Code C9070
Injection, tafasitamab-cxix, 2 mg
| Notice | HCPCS C9070 terminated on March 31, 2021. |
| Short Description | Injection, tafasitamab-cxix |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2021 |
| HCPCS Code Added Date | January 01, 2021 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 9 - Other medical items or services |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9085 - Inj avalglucosid alfa-ngpt
- C9086 - Inj, anifrolumab-fnia
- C9087 - Inj cyclophosphamd auromedic
- C9088 - Instill, bupivac and meloxic
- C9089 - Bupivacaine implant, 1 mg
- C9090 - Plasminogen, human-tvmh 1 mg
- C9091 - Sirolimus, protein-bound,1mg
- C9092 - Inj., xipere, 1 mg
- C9093 - Inj., susvimo, 0.1 mg
- C9094 - Inj, sutimlimab-jome, 10 mg
- C9095 - Inj, tebentafusp-tebn, 1 mcg
- C9096 - Inj, releuko, 1 mcg
- C9097 - Inj, faricimab-svoa, 0.1 mg
- C9098 - Ciltacabtagene car pos t
- C9101 - Inj, oliceridine 0.1 mg
- C9113 - Inj pantoprazole sodium, via
- C9121 - Injection, argatroban
- C9122 - Mometasone furoate (sinuva)
- C9132 - Kcentra, per i.u.
- C9133 - Factor ix recombinant